| Sources | Names Used |
|---|---|
| CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
| PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DCUN1D2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | HOXD10 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ZNF532 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | OTUD3 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | CTD-2192J16.17 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ESRRG | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | RP13-672B3.2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | MFAP5 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | QPRT | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | BCL7A | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
